Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1993 Feb 6;306(6874):371–373. doi: 10.1136/bmj.306.6874.371

Clinical symptoms associated with seroconversion for HIV-1 among misusers of intravenous drugs: comparison with homosexual seroconverters and infected and non-infected intravenous drug misusers.

G H Mientjes 1, E J van Ameijden 1, H M Weigel 1, J A van den Hoek 1, R A Coutinho 1
PMCID: PMC1676469  PMID: 8461683

Abstract

OBJECTIVE--To study the clinical symptoms associated with seroconversion for HIV-1 among misusers of intravenous drugs. DESIGN--Case-control study in cohorts of drug misusers and homosexual men. SETTING--Outpatient clinic, Municipal Health Service, Amsterdam. SUBJECTS--Misusers of intravenous drugs from our prospective cohort who seroconverted for HIV. Controls were drug users positive for HIV, drug users negative for HIV, and homosexual men who had seroconverted. RESULTS--Five out of 18 (28%) drug users were admitted to hospital with bacterial pneumonia in the four to six months between their last visit at which they were HIV negative and their first visit when they were HIV positive. For comparison none of the 27 homosexual men who seroconverted for HIV, three out of 177 (2%) drug users negative for HIV, and 10 out of 112 (9%) drug users positive for HIV reported bacterial pneumonia. One out of the 18 drug users who seroconverted suffered from oesophageal candidiasis at the time of seroconversion. Other clinical symptoms did not differ between drug users who seroconverted and those who remained negative for HIV, probably due to the high background morbidity among the drug users. CONCLUSIONS--Seroconversion to HIV-1 among intravenous drug misusers is associated with bacterial pneumonia. Those drug users with previously negative test results for HIV who are admitted to hospital for bacterial pneumonia should be tested to detect primary infection with HIV-1.

Full text

PDF
371

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloemena E., Roos M. T., Van Heijst J. L., Vossen J. M., Schellekens P. T. Whole-blood lymphocyte cultures. J Immunol Methods. 1989 Sep 1;122(2):161–167. doi: 10.1016/0022-1759(89)90260-3. [DOI] [PubMed] [Google Scholar]
  2. Grieco M. H., Reddy M. M., Fusillo C. A., Sorrell S. J., Buimovici-Klein E., Gindi E. J., Brown D. K., Saxinger W. C., Weiss S. H., Flaster E. R. Cross-sectional study of immunologic abnormalities in intravenous drug abusers on methadone maintenance in New York City. AIDS. 1989 Apr;3(4):235–237. doi: 10.1097/00002030-198904000-00007. [DOI] [PubMed] [Google Scholar]
  3. Louria D. B., Hensle T., Rose J. The major medical complications of heroin addiction. Ann Intern Med. 1967 Jul;67(1):1–22. doi: 10.7326/0003-4819-67-1-1. [DOI] [PubMed] [Google Scholar]
  4. Manos G. E., van Deutekom H., Peerbooms P. G., van Doornum G. J., Coutinho R. A. Community-acquired pneumonia in drug abusers in Amsterdam. Lancet. 1990 Oct 13;336(8720):939–940. doi: 10.1016/0140-6736(90)92308-5. [DOI] [PubMed] [Google Scholar]
  5. Mientjes G. H., Miedema F., van Ameijden E. J., van den Hoek A. A., Schellekens P. T., Roos M. T., Coutinho R. A. Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users. AIDS. 1991 Jan;5(1):35–41. doi: 10.1097/00002030-199101000-00005. [DOI] [PubMed] [Google Scholar]
  6. Mientjes G. H., van Ameijden E. J., van den Hoek A. J., Coutinho R. A. Increasing morbidity without rise in non-AIDS mortality among HIV-infected intravenous drug users in Amsterdam. AIDS. 1992 Feb;6(2):207–212. doi: 10.1097/00002030-199202000-00012. [DOI] [PubMed] [Google Scholar]
  7. Parkin J. M., Helbert M., Hughes C. L., Pinching A. J. Immunoglobulin G subclass deficiency and susceptibility to pyogenic infections in patients with AIDS-related complex and AIDS. AIDS. 1989 Jan;3(1):37–39. [PubMed] [Google Scholar]
  8. Peña J. M., Martínez-López M. A., Arnalich F., Barbado F. J., Vázquez J. J. Esophageal candidiasis associated with acute infection due to human immunodeficiency virus: case report and review. Rev Infect Dis. 1991 Sep-Oct;13(5):872–875. [PubMed] [Google Scholar]
  9. Scheidegger C., Zimmerli W. Infectious complications in drug addicts: seven-year review of 269 hospitalized narcotics abusers in Switzerland. Rev Infect Dis. 1989 May-Jun;11(3):486–493. doi: 10.1093/clinids/11.3.486. [DOI] [PubMed] [Google Scholar]
  10. Selwyn P. A., Hartel D., Wasserman W., Drucker E. Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am J Public Health. 1989 Oct;79(10):1358–1362. doi: 10.2105/ajph.79.10.1358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tindall B., Hing M., Edwards P., Barnes T., Mackie A., Cooper D. A. Severe clinical manifestations of primary HIV infection. AIDS. 1989 Nov;3(11):747–749. doi: 10.1097/00002030-198911000-00010. [DOI] [PubMed] [Google Scholar]
  12. Witt D. J., Craven D. E., McCabe W. R. Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med. 1987 May;82(5):900–906. doi: 10.1016/0002-9343(87)90150-1. [DOI] [PubMed] [Google Scholar]
  13. de Jong M. D., Hulsebosch H. J., Lange J. M. Clinical, virological and immunological features of primary HIV-1 infection. Genitourin Med. 1991 Oct;67(5):367–373. doi: 10.1136/sti.67.5.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. van den Hoek J. A., Coutinho R. A., van Haastrecht H. J., van Zadelhoff A. W., Goudsmit J. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS. 1988 Feb;2(1):55–60. doi: 10.1097/00002030-198802000-00010. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES